Ferric Derisomaltose Patent Expiration
Ferric Derisomaltose is Used for treating iron deficiency anemia in adult patients with intolerance to oral iron or unsatisfactory response to oral iron, and non-hemodialysis dependent chronic kidney disease, by administering ferric derisomaltose. It was first introduced by Pharmacosmos As
Ferric Derisomaltose Patents
Given below is the list of patents protecting Ferric Derisomaltose, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Monoferric | US10414831 | Stable iron oligosaccharide compound | Mar 25, 2029 | Pharmacosmos As |
Monoferric | US11633489 | Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant | Jun 22, 2036 | Pharmacosmos As |
Monoferric | US8815301 | Stable iron oligosaccharide compound | Aug 14, 2029 | Pharmacosmos As |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳